Sihuan Pharmaceutical Holdings Group Ltd. (03309) announced that the board of directors of the company was informed by the company's chairman, CEO and executive director, Lin Shunchao, that he had purchased a total of 0.348 million shares of the company's stock in the market on July 22, 2024, at a total cost of HKD 0.9203 million, equivalent to an average price of about HKD 2.64 per share and accounting for approximately 0.028% of the company's issued share capital.
Clear
All
Quotes
News
Learn
Help
All
US
HK
CN
SG
AU
JP
All
News
Announcements
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
希玛医疗获公司行政总裁兼执行董事林顺潮增持34.8万股公司股份
Hima Medical received an increase in shareholding of 0.348 million shares of the company's stock from the CEO and executive director, Lin Shunchao.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Like
1
Views 271
Write a comment
1
Statement
This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report